Back to results
US 12,661,373 B2Granted
Electrochemically activated salt solution
AssigneeAzad Pharma AG
InventorsMihran Baronian, Fabio Carli, Elisabetta Chiellini, Ernest Baehler
Life of this patent
Estimating the term…
Abstract
The present application refers to an electrochemically activated salt solution (ECAS), its production, and its use for treating infections.
Claims12
A closed high-density polyethylene (HDPE) container comprising:
- an electrochemically activated salt solution (ECAS) stored in the closed HDPE container, wherein the ECAS comprises:
- a content of total chlorine of between 100 and 450 mg/l,
- a content of chloride of between 3 and 7 g/l,
- a redox potential of +700 to +1,050 mV,
- an osmolality of 250-350 mOsm/kg,
- a pH value of 7.1-7.8, and
- at least one of boric acid, a salt of boric acid, phosphoric acid, and a salt of phosphoric acid,
- wherein, if present, the boric acid or the salt of boric acid is in an amount of 0.1-500 g/l,
- wherein, if present, the phosphoric acid or the salt of phosphoric acid is in an amount of 0.1-100 g/l, and
- wherein the redox potential of the ECAS stored in the closed HDPE container is reduced by 10% or less after storage for one year at 20° C.
7 more elements
Dependencies are inferred from the claim text.